Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
House approves clinical research measure to study psychedelic-assisted PTSD treatments for veterans
Summary
The House passed first substitute HB 390 to establish a tightly controlled clinical research program studying psychedelic-assisted treatments for treatment-resistant PTSD among veterans, to be conducted at Huntsman Mental Health Institute under FDA/DEA and IRB protocols.
The Utah House on Feb. 18 approved first substitute House Bill 390 to create a clinical research pathway for psychedelic-assisted treatments targeting treatment-resistant PTSD in the veteran population. Representative Daley Provo, sponsor of the bill, described the measure as narrowly focused on research conducted under strict protocols at Huntsman Mental Health Institute with oversight from the FDA, DEA and university…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
